Statistics
Publications
3
Citations
290
H-Index
3
Active since
2020
F. La Rosée is an author at Schwarzwald-Baar Klinikum specializing in multiorgan failure management, inflammatory disease pharmacotherapy, and inflammatory response regulation.
Publications per year
2020–2024
3
3
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
F. La Rosée, Hinrich Bremer, Iris Gehrke et al. · Leukemia · 2020 · 243 citations · Full text
HLH: diagnostics revisited and improved
Paul La Rosée, F. La Rosée · Blood · 2024 · 19 citations
1–3 of 3